Abstract
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have